Article
Isocitrate dehydrogenase mutations in gliomas.
Neuro-oncology - 1 Jan 2016
Waitkus Matthew S, Diplas Bill H, Yan Hai
Abstract excerpt
Over the last decade, extraordinary progress has been made in elucidating the underlying genetic causes of gliomas. In 2008, our understanding of glioma genetics was revolutionized when mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) were identified in the vast majority of progressive gliomas and secondary glioblastomas (GBMs). IDH enzymes normally catalyze the decarboxylation of isocitrate to generate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
